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Background: Many of the approximately 15 million people with a migration background living in Germany (19% of
the population) are inadequately reached by existing healthcare provision. In the literature, the necessity for cultural
adaptation of information material for patients with a migration background is often cited as a measure for improving
healthcare.
In this study, culturally sensitive information material will be developed and evaluated for patients with a migration
background and depression or chronic low back pain. In this respect, it will be examined whether culturally sensitive
information material is judged as more useful by the patients than standard translated patient information without
cultural adaptation.
Methods/Design: The implementation and evaluation of culturally sensitive patient information material will occur in
the framework of a double-blind randomized controlled parallel-group study in four study centres in Germany. Primary
care patients with a Turkish, Polish, Russian or Italian migration background with a diagnosis of depressive disorder or
chronic low back pain will be included and randomly allocated to the intervention group or the control group. In the
intervention group, culturally sensitive patient information will be handed to the patient at the end of the physician
consultation, while in the control group, standard translated patient information material will be provided. The patients
will be surveyed by means of questionnaires following the consultation as well as after 8 weeks and 6 months.
In addition to the primary outcome (subjective usefulness), several patient- and physician-rated secondary outcomes
will be considered.
Discussion: The study will provide an empirical answer to the question of whether persons with a migration
background perceive culturally sensitive patient information material as more useful than translated information
material without cultural adaptation.
Trial registration: Deutsches Register Klinischer Studien (DRKS-ID) DRKS00004241 and Universal Trial Number (UTN)
U1111-1135-8043.
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A person’s healthcare is influenced by cultural and ethical
values and attitudes as well as his or her migration experi-
ences [1-3]. Language difficulties, a lack of information on
the host country’s healthcare system and healthcare
provision, deviating cultural beliefs, and a feeling of being
misunderstood are central problems in the healthcare of
persons with a migration background [4,5]. These barriers
may be of elevated importance in chronic and multifactori-
ally determined diseases, in which lifestyle changes are
required for an enduring treatment success, for example,
depression or chronic low back pain. To ensure successful
changes in lifestyle, patients have to be adequately in-
formed. An efficient way to inform patients is provided
by written patient information material (for example,
brochures), which increases knowledge about the illness
and its treatment and is therefore a notable supplement to
the consultation [6]. Patient information material can help
the patient to develop a realistic perception of the course of
the disease and increase his or her involvement [7]. It
supports patients by informing them about sensible self-
help activities and advising how to improve coping strat-
egies [8]. Moreover, it helps patients to become aware of
their own preferences when different treatment options are
given and to make informed decisions.
When addressing patients with a migration background,
merely translating patient information material into the
patient’s mother tongue might not be sufficient to deal with
cultural barriers. The understanding of the concepts of
‘health’ and ‘disease’ depends on the sociocultural context
of a country, and therefore culturally sensitive information
material that is designed to meet the unique needs of
migrants has been called for [9]. Such material might help
to improve the healthcare of persons with a migration
background, by reducing cultural barriers and facilitating
effective communication to help them to recognise and
cope actively with diseases [9,10]. However, research on the
effects of culturally sensitive patient information material is
insufficient. To date, high-quality investigations focusing on
the specific effect of culturally sensitive material compared
with high-quality standard translations using a double-blind,
randomized controlled multicentre design are lacking.Objectives
The aim of our study is to evaluate the effects of the
provision of culturally sensitive information material to
primary care patients with a migration background with
depression or chronic low back pain in comparison with
that of non-culturally adapted material. This will be
assessed with regard to perceived usefulness of the
material as judged by the patient (primary outcome) and
other short- and medium-term cognitive, behavioural,
clinical and healthcare-related outcomes.Methods/Design
The effects of a culturally sensitive version of written
patient information material compared with a standard
translated version will be evaluated in a double-blind,
randomized controlled multicentre trial involving four
study centres. Participating study centres are the Research
Group on Psychotherapy and Health Services Research,
Department of Psychiatry and Psychotherapy, Medical
Center - University of Freiburg (primary study centre); the
Department of Medical Psychology, University Medical
Center Hamburg-Eppendorf; the German Foundation
Against Depression (Stiftung Deutsche Depressionshilfe);
and the Network of Physicians Oberhausen-Mülheim-
Duisburg (Ärzte Netzverbund Oberhausen-Mülheim-
Duisburg). The study was approved by the institutional
review board of the University Medical Center Freiburg
(number 375/10) and the local review boards responsible
for local physicians (Ärztekammer Nordrhein, number
2012400; Sächsische Landesärztekammer, number EK-BR-
74/12-1; Landesärztekammer Baden-Württemberg, number
B-F-2012-065, and Ärztekammer Hamburg, number MC-
307/12).
We chose depressive disorders and low back pain as
medical indications as both conditions are among the
leading causes of burden of disease worldwide [11]. Both
conditions are often chronic, require an active involvement
of patients in their own healthcare and are expected to be
sensitive to cultural background. In addition, they are
highly prevalent in German primary care [12,13].
To further increase generalizability, we chose to include
patients with various migration backgrounds. Persons with
a Turkish origin were included, as they constitute the
largest group of migrants in Germany. Polish migrants are
the group with the highest percentage of recent immigrants
and the third largest group in total. Russian migrants are
often late re-settlers with a German origin. Italian migrants
are the largest group of European Union migrants and are
among the traditional migrant workers in Germany.
The majority of patients are treated in primary care.
Moreover, patient information plays a central role in
primary care because it often serves as the source of first
contact. General practitioners therefore have to provide
initial information about illness and corresponding treat-
ment options. Given the high numbers of patients treated
in primary care and the central role of information material
in this setting, we chose primary care as the setting for our
study.
Inclusion criteria
General practitioners will consecutively assess patients for
eligibility. Adult primary care patients with a Turkish,
Polish, Russian or Italian migration background and with
unipolar depressive disorder or non-specific chronic low
back pain will be included. Having a migration background
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language other than German, being born in another coun-
try, or having a parent who was born in a country other
than Germany. To be included, patients have to report that
they perceive their non-German origin as part of their iden-
tity. Unipolar depressive disorder is defined according to
the International Classification of Disease, 10th revision
(ICD-10: codes F32.xx, F33.xx, F34.1). In accordance with
German national guidelines, chronic low back pain is
defined as pain in the area beneath the costal arch, above
the inferior gluteal folds, with or without referred leg pain,
for more than 12 weeks and without signs of a specific
cause (ICD-10 codes: M54.5, M54.8, M54.9). Potentially
eligible patients will be identified using routine health
records. Sociodemographic information will be confirmed
within the consultation. Diagnosis will be based on clinical
judgment.
Exclusion criteria
To ensure a high external validity of our results, we have
not formulated any exclusion criteria. However, owing to
the type of intervention (written patient information
material) and the response format (questionnaire), patients
who are unable to read or respond to a questionnaire in the
language of their respective migration background will not
be eligible to participate in this study.
Recruitment of general practitioners
General practitioners will be recruited by inviting academic
training practices, practices of the cooperating networks and
general practitioners (using public registers) to participate in
the study. General practitioners will receive an allowance of
€40.00 per patient recruited.
Development of the interventions
In a first step, we will develop written patient information
material for the indication of unipolar depression and
chronic low back pain on the basis of current clinical prac-
tice guidelines (for depression, [12]; for chronic low back
pain, [14]) in the German language. In addition to informa-
tion on epidemiology, diagnostics and prognosis, treatment
options and responsibilities of different healthcare providers
will be explained using comprehensible language. The con-
tent of the developed patient information material will be
discussed in an expert workshop with respect to accuracy
and comprehensibility. To ensure the high quality of the
material, we will include healthcare professionals (including
at least one professional who was engaged in the develop-
ment of the respective guideline) as well as patient repre-
sentatives in the process. The final brochure comprises 12
pages and includes figures, pictures and illustrative case
examples.
Second, the material will be translated by professional
translators using the forward-backward translation procedure[15]. To this aim, the material will be translated by two
independent translators. Based on the two versions, a third
independent translator will develop a consensual version,
and the consensual version will be translated back into
German by a fourth independent translator. The original
version and the back-translated version will be cross-
checked by the third translator in cooperation with the
research team. This process guarantees a high quality of the
translated patient information material. The resulting
material, termed the ‘standard translated version’, will be
used as the control condition.
Third, cultural differences in the respective countries will
be explored in order to develop the culturally sensitive
version of the patient information material. The translated
patient information material will be discussed with respect
to its cultural appropriateness in four separate focus
groups, one for each nationality. The focus groups will
consist of four to ten people with a migration background.
All focus groups will be conducted by the same moderators
using a manual. The focus group sessions will be audio-
recorded and transcribed. Two independent researchers
will perform content analysis according to the methods of
Mayring and Schreier [16,17]. Differences will be resolved
by discussion with a third independent researcher. Based
on these results, a culturally sensitive version of the patient
information material will be developed. Cultural adaptations
will primarily focus on presentation; the core information
will remain unchanged.
Fourth, comprehensibility of the culturally sensitive version
will be pilot-tested with two persons per migrant group. In
this step, only definitely misleading or incomprehensible
expressions will be modified. The resulting culturally
sensitive version of the material will then be used in the
intervention group.
Administration
Patients will be recruited and informed of the study by the
participating general practitioners within the consultation
(−T1, enrolment, see Table 1). Informed consent will be
sought from each participating patient. After informed
consent has been provided, patients will receive a sealed
envelope containing written patient information material in
the form of a brochure and a questionnaire (T0, allocation).
The contents of the envelopes (standard translated material
versus culturally sensitive material) will be centrally ran-
domized by means of a computer-based algorithm and
stratified by physician, disease and migration background
(Turkey, Poland, Russia, Italy) with varying block sizes, to
ensure a balanced proportion of participants in the study
conditions and to prevent predictability. Each physician,
provided in advance with sets of envelopes, according to
the disease and the migration background of the eligible
patient, will simply hand the patient the next envelope from
the appropriate group of envelopes. The envelopes will be
Table 1 Study schedule
Study period
Enrolment Allocation Post-allocation Close-out






Culturally sensitive patient information material ×







Demographic information (age, sex, migration background,
mother tongue, German language proficiency, education)*
×
Acculturation (SMAS) ×
Usefulness of information material (USE) × × ×
Knowledge of the disease* × × ×
Perceived cultural sensitivity* ×
Behaviour change* × ×
Illness perception (Brief-IPQ) × × ×
Symptom self-rating (PHQ-9, Core set) × × ×
Acceptance of the disease or treatment* × × ×
Adherence (MOS) × ×
Satisfaction with physician (ZAPA) × × ×
Health care utilization* × ×
Quality of life (WHO-5) × × ×
−T1, within the consultation; T0, after informed consent has been given; T1, after consultation; T2, 8 weeks; T3, 6 months; Brief-IPQ, Brief Illness Perception Questionnaire;
MOS, Medical Outcomes Study (general adherence); PHQ-9, 9-item version of the Patient Health Questionnaire; SMAS, Stephenson Multigroup Acculturation Scale; USE,
Usefulness Scale for Patient Information Material; WHO-5, WHO 5 Well-being Index; ZAPA, questionnaire assessing satisfaction with outpatient care, with a focus on
patient participation; *, self-constructed items.
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contact with patients. Blinding of general physicians and
patients will be ensured through the use of sealed enve-
lopes. Concomitant care will not be restricted in any way.
Patients in the intervention group will receive a culturally
sensitive version and patients in the control group will
receive a standard translated version of brochures. Patients
will read the brochures after the end of the consultation,
and will be asked to fill in the questionnaire and return it
by post using a prepaid envelope (T1, after consultation). If
patients do not respond, they will be reminded by phone (if
possible) after 2 weeks and by post after 3 weeks. At 8 weeks
(T2) and 6 months (T3) after the consultation, patients will
be contacted by post and asked to fill in follow-up
questionnaires. To ensure a sufficient response rate ateach time point, patients will receive an unconditional
reimbursement of €5.00, as this measure has been shown
to be associated with an increased response rate [18].
Primary outcome
The primary outcome will be the perceived usefulness of
the written patient information material, as assessed by the
patient using the Usefulness Scale for Patient Information
Material (USE) following the consultation (T1). Patients will
be blinded to their group assignment. This scale was
developed in an independent inpatient population of 120
patients with depression or chronic low back pain. It is an
instrument to measure the perceived usefulness of written
patient information material from a patient’s point of view,
and has nine items. The total score of the final version is a
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differentiate cognitive, emotional and behavioural aspects
of usefulness. The USE has turned out to be a reliable and
valid scale.
Secondary outcomes
Perceived usefulness (USE) will additionally be assessed at
T2 and T3, to investigate the perception of usefulness of the
information material over time. Differences in the subscales
will additionally be assessed. We will additionally assess the
effects of the culturally sensitive material on knowledge of
the disease (self-constructed items; at T1, T2, T3) and
whether adapted patient information material is perceived
as more culturally adequate (perceived cultural sensitivity;
self-constructed items; T1). In addition, the level of imple-
mentation of behaviour promoted in the patient informa-
tion material (behaviour change; self-constructed items;
T2, T3), perception of disease (Brief Illness Perception
Questionnaire, Brief-IPQ; T1, T2, T3 [19]), symptoms of
depression or back pain (Patient Health Questionnaire,
PHQ-9, Core set; T1, T2, T3 [20,21]), and acceptance of dis-
ease and the treatment (self-constructed items; T1, T2, T3)
will be investigated. Finally, the effects of the culturally
sensitive material on adherence (MOS general adherence
items; T2, T3 [22]), Satisfaction with the physician (ZAPA;
T1, T2, T3 [23]), healthcare utilization (self-constructed
items; T2, T3) and quality of life (WHO 5 Well-being Index,
WHO-5; T1, T2, T3 [24]) will be assessed.
Additional parameters
Data on the following demographic parameters will be
collected via self-rating questionnaire: age, sex, migration
background, mother tongue, German language proficiency
and education. The acculturation of the patient will add-
itionally be captured by means of a standardized instrument
(Stephenson Multigroup Acculturation Scale, SMAS; T1
[25]). Moreover, physicians will be asked about the patient’s
diagnosis and treatment.
At the level of the general practitioner, we will assess
general characteristics of the physician, such as age, sex,
migration background, mother tongue and level of experi-
ence with other cultures via a self-rating questionnaire, to
gain information on the generalizability of the results. At
the level of the general practitioners’ practice, we will gather
information on the number of practitioners in the practice,
case load, consultations conducted in languages other than
German, practice staff with a migration background,
whether patient information material in languages other
than German is already offered, and general practitioners’
estimated usefulness of patient information material for
people with a migration background. Finally, we will assess
the self-rated competence of the physician in dealing with
persons with a migration background, the subjective need
for education in dealing with persons with a migrationbackground, the perceived impact of interaction problems
and other barriers to treating persons with a migration
background.
Statistical analyses
The primary outcome (usefulness of written patient infor-
mation material; USE) will be analyzed by a blinded statisti-
cian with a one-sided t test comparing the scores on the
USE scale between the intervention and the control group.
Secondary interval-scaled outcomes will be tested using
t tests and analysis of covariance (ANCOVA, if baseline
measurement of the outcome is available). In additional
analyses, we will include acculturation (SMAS) as covariate
and conduct subgroup analyses regarding disease, migration
background, symptom severity and acculturation. The pri-
mary analysis will be performed according to the intention-
to-treat principle, including all randomized participants.
Missing data will be handled by applying linear mixed
models and expectation-maximisation imputation. Secondary
analyses will be performed in available cases.
Sample size
To be able to identify a small intervention effect (Cohen’s d
of 0.3, which corresponds to a difference of 6 points in the
USE (assuming a standard deviation of 20)) with a Type I
error of 0.05 and a power of 80%, a total sample size of 280
patients (140 per group) is needed for statistical analysis.
Taking into account a dropout rate of about 40% (patients
who give informed consent but do not return the question-
naire by post), 480 patients shall be recruited. In the
intention-to-treat analysis, the larger number of patients is
expected to be compensated by a dilution of effects, meaning
that the power will be approximately the same as in the
available case analysis.
Discussion
Our study will provide information on the effects of cultur-
ally sensitive patient information material in primary care
on central patient-reported outcomes, such as perceived
usefulness, disease-related knowledge, behaviour change,
perception of disease, illness symptoms, acceptance of
disease and treatment, adherence, satisfaction with the
physician, health service utilization, and quality of life. This
will be the first study to use a double-blind, randomized
controlled multicentre design to evaluate the effects of
culturally sensitive information material. By blinding both
patients and the responsible physician, we are likely to
control bias caused by expectations. The inclusion of different
diseases and migration groups and the recruitment in
multiple centres in different areas in Germany should
ensure a high external validity of the results.
A central challenge of our study is the complexity of the
intervention. The term ‘cultural adaptation’ is not consist-
ently defined in the literature and there are many different
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adapted. Therefore, results might be specific to the type of
cultural adaptation chosen for our study. However, we aim
to describe the process of our cultural adaptation in detail
and make it publicly available, to enable a replication and
critical discussion of our results. We will take several
measures to assure a high quality of the cultural adaptation
process and the resulting culturally sensitive patient
information material. To ensure a high external validity,
only people with a migration background who are living in
Germany will be invited to participate in the focus groups.
All focus group sessions will be conducted by the same
moderators using manuals to ensure high comparability. A
high objectivity of our results will be ensured by the use of
audio-recording and transcription of the focus group
sessions and by the involvement of at least two independent
researchers in the analyses of the results.
Potential limitations of the study are that the inclusion
criteria (especially the diagnosis) are exclusively based on
the clinical judgment of the general practitioners. For feasi-
bility reasons, we chose to include patients regardless of the
reason for consultation and we did not specify the timing
in the disease course when the patients are eligible. This
may dilute the effects of the intervention. Another limita-
tion is that patients have to self-administer a high number
of scales. This might hinder the feasibility of the trial and
reduce the response rate. Moreover, the use of several self-
constructed scales may be critical, as validity and reliability
are unknown for some of the scales.
It has often been stressed that cultural adaptation of
patient information material is crucial for improving the
healthcare of patients with a migration background. How-
ever, high-quality studies dealing with this issue are largely
lacking. Our study might therefore close an important
knowledge gap. The results of our study may have a major
impact on health services for patients with a migration
background, as they will enable the incremental effect of
culturally sensitive patient information material compared
with high-quality standard translated material in primary
care to be estimated.
Trial status
The first patient was enrolled in June 2013. At the time
of manuscript submission, participants were still being
recruited.
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